August 12, 2015

ATTENTION Advanced Investors and Finance Professionals:
If you are reading this you should download ValuEngine Institutional Software to see how VE’s powerful quantitative tools can increase your productivity and effectiveness.

VALUATION WATCH: Overvalued stocks now make up 47.18% of our stocks assigned a valuation and 16.13% of those equities are calculated to be overvalued by 20% or more. Eight sectors are calculated to be overvalued--with two at or near double digits.

--Not So Generic

TEVA Pharmaceuticals is Upgraded by ValuEngine

TEVA Pharmaceuticals USA (TEVA), the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.

When we query our systems for the top STRONG BUY upgrades today, TEVA Pharma leads the results. Members can always screen for these stocks using our advanced screening page HERE or our 5-Engine Stock page HERE.

ValuEngine updated its recommendation from BUY to STRONG BUY for TEVA PHARM ADR on 2015-08-11. Based on the information we have gathered and our resulting research, we feel that TEVA PHARM ADR has the probability to OUTPERFORM average market performance for the next year. The company exhibits ATTRACTIVE Company Size and Momentum.

Below is today's more extensive data on TEVA:

ValuEngine Forecast
	Target Price*	Expected Return
1-Month	70.36	1.09%
3-Month	72.25	3.81%
6-Month	75.15	7.98%
1-Year	78.68	13.05%
2-Year	88.66	27.39%
3-Year	62.72	-9.89%

Valuation & Rankings
Valuation	38.78% overvalued	Valuation Rank(?)	7
1-M Forecast Return	1.09%	1-M Forecast Return Rank	98
12-M Return	35.70%	Momentum Rank(?)	90
Sharpe Ratio	0.33	Sharpe Ratio Rank(?)	71
5-Y Avg Annual Return	6.91%	5-Y Avg Annual Rtn Rank	67
Volatility	20.76%	Volatility Rank(?)	73
Expected EPS Growth	-4.07%	EPS Growth Rank(?)	21
Market Cap (billions)	59.51	Size Rank	99
Trailing P/E Ratio	12.88	Trailing P/E Rank(?)	83
Forward P/E Ratio	13.43	Forward P/E Ratio Rank	67
PEG Ratio	n/a	PEG Ratio Rank	n/a
Price/Sales	2.95	Price/Sales Rank(?)	32
Market/Book	2.58	Market/Book Rank(?)	43
Beta	0.68	Beta Rank	59
Alpha	0.20	Alpha Rank	87

ValuEngine.com is an independent research provider, producing buy/hold/sell recommendations, target price, and valuations on over 5,000 US and Canadian equities every trading day.
Visit our website for more information and a free trial.

As a bonus to our Newsletter readers,
we are offering a FREE DOWNLOAD of one of our Stock Reports

Read our Complete Detailed Valuation Report on TEVA HERE.

Want To Know More About Our ValuEngine View Newsletter?

Looking for a monthly portfolio of stock picks which are objective and based on cutting-edge academic theory and Wall St.practice? Then subscribe to The ValuEngine View Newsletter.The ValuEngine View Portfolio is based on our highly-refined and tested ValuEngine Portfolio Strategies along with our proprietary quant-based composite scoring system. The ValuEngine View Newsletter is the product of sophisticated stock valuation and forecast models first developed by Yale Professor of Finance Zhiwu Chen.

The ValuEngine View Newsletter is the product of a sophisticated stock valuation model that was first developed by ValuEngine's academic research team. It utilizes a three factor approach: fundamental variables such as a company's trailing 12-month Earnings-Per-Share (EPS), the analyst consensus estimate of the company's future 12-month EPS, and the 30-year Treasury yield are all used to create a more accurate reflection of a company's fair value. A total of eleven additional firm specific variables are also used. In addition, the portoflio uses top picks from our Forecast Model. In essence, the portfolio is constructed with the best picks from our main propiretary models

Each month you will receive an electronic copy of our newsletter highlighting 15 potential long positions along with five alternate picks. Our investment strategies focus on dozens of fundamental and technical factors for over 8000 individual stocks, synthesize the data, and then come up with a portfolio. Each newsletter portfolio focuses on maximum potential returns so there are no diversity requirements. Each portfolio pick includes critical ValuEngine valuation and forecast data. These 20 total picks represent the most up-to-date equity assessments of our proprietary models.

Please click HERE to subscribe. You may download a sample copy HERE. After your subscription is approved, you will immediately receive access to download the current issue of newsletter as well as the previous issues, which are all available as PDF files. Each month when the latest issue of the newsletter is released, we will send you an email, informing you to download it from the site. The newsletter is released near the middle of each month.

	VE View	S&P 500
VE View vs. S&P 500 Index Past Five Years
Ann Return	19.75%	14.13%
Ann Volatility	21.06%	11.13%
Sharpe Ratio	0.94	1.27
Sortino Ratio	1.55	1.56
Max Drawdown	-34.94%	-11.14%

The ValuEngine View Newsletter is derived from the ValuEngine Aggressive and Diversified Growth BenchmarkPortfolio Strategies. These strategies are the product of ValuEngine's academic research team and combine cutting-edge financial analysis and portfolio construction techniques with real-world Wall St. know how.

CLICK HERE to Subscribe to the ValuEngine View

The ValuEngine View Newsletter portfolio has 15 primary stock picks and five alternates and is re-balanced once each month. The ValuEngine View Newsletter is published near the middle of each calendar month. An equal amount of capital is allocated to each stock. The monthly returns are calculated from the closing prices on date of publication. The performance calculation does not include any transaction costs.

ValuEngine Market Overview

Summary of VE Stock Universe
Stocks Undervalued	52.82%
Stocks Overvalued	47.18%
Stocks Undervalued by 20%	20.88%
Stocks Overvalued by 20%	16.13%

ValuEngine Sector Overview

Sector	Change	MTD	YTD	Valuation	Last 12-MReturn	P/E Ratio
Aerospace	-2.13%	-1.31%	3.73%	11.70% overvalued	-0.06%	20.76
Medical	-1.05%	-2.56%	13.04%	10.53% overvalued	14.18%	31.97
Consumer Staples	-1.00%	-1.35%	-0.28%	6.82% overvalued	0.42%	23.28
Business Services	-0.68%	-1.41%	4.48%	5.40% overvalued	-1.11%	24.18
Retail-Wholesale	-0.64%	-1.75%	-2.80%	2.55% overvalued	5.42%	25.16
Consumer Discretionary	-0.96%	-1.15%	5.68%	2.24% overvalued	-0.97%	28.38
Finance	-0.63%	-0.73%	1.47%	1.65% overvalued	0.02%	17.48
Computer and Technology	-1.21%	-1.52%	-1.41%	0.20% overvalued	-1.92%	28.92
Multi-Sector Conglomerates	-0.39%	-2.62%	-4.15%	0.57% undervalued	-8.35%	22.16
Utilities	-0.64%	-1.20%	-4.53%	1.26% undervalued	-5.02%	22.00
Construction	-0.97%	-0.25%	1.75%	4.59% undervalued	1.58%	24.03
Industrial Products	-1.46%	-1.32%	-2.69%	4.60% undervalued	-9.47%	18.93
Transportation	-1.18%	-1.96%	-4.94%	5.22% undervalued	-6.16%	17.16
Auto-Tires-Trucks	-1.64%	-0.84%	-1.52%	5.59% undervalued	-8.18%	15.70
Oils-Energy	-1.19%	-2.83%	-14.14%	13.41% undervalued	-45.19%	24.32
Basic Materials	-0.89%	0.83%	-11.35%	15.67% undervalued	-34.13%	21.77

ValuEngine.com Products and Services

With the ValuEngine Forecast 16 Market Neutral Strategy Portfolio Newsletter, you can run your own portfolio like a hedge fund to manage risk and profit in any market environment.	Click HERE to Sign Up for ValuEngine's Market Neutral Newsletter
With ValuEngine.com's Premium Website Membership you get forecasts, valuations, and recommendations on more than 7,000 stocks updated every trading day! NO OBLIGATION, 14-DAY FREE TRIAL!	Click HERE to Sign Up for a FREE TRIAL